Abstract
Infectious bursal disease is one of the most important viral diseases in the young chickens. VP2 protein is the major host protective immunogen of the virus. A hypervariable region is present in VP2 protein (hvVP2) that contains immunodominant epitops. The high hydrophobicity of hvVP2 region causes protein aggregation in Escherichia coli (E. coli). The objective of the present study was to improve the expression and the solubility of the hvVP2 protein in E. coli. The effects of fusion partners on the solubility of hvVP2 protein were studied. The protein was expressed in forms of unfused and N-terminally fused to GST and NusA. The results showed that the unfused hvVP2 protein was expressed in very low level. But, N-terminally fused hvVP2 protein to GST (glutathione-S-transferase) and NusA (N utilization substance A) showed significantly enhanced protein expression. The fusion of GST and hvVP2 was produced in aggregated form while in the presence of NusA, the hvVP2 protein was expressed in a soluble form. The NusA-hvVP2 protein was detected by a neutralizing monoclonal antibody, 1A6, in antigen-capture ELISA. In conclusion, the NusA protein is a suitable fusion partner to improve expression and solubility of the hvVP2 protein in E. coli.
Similar content being viewed by others
Abbreviations
- ABTS:
-
2-2′-azino-di-(3-ethylbenzthiazoline sulfonic acid)
- DAB:
-
3,3′-diaminobenzidine
- GST:
-
Glutathione-S-transferase
- HRP:
-
Horseradish peroxidase
- hvVP2:
-
Hypervariable region of VP2 protein
- IBD:
-
Infectious bursal disease
- IBDV:
-
Infectious bursal disease virus
- IMAC:
-
Immobilized metal-affinity chromatography
- IPTG:
-
Isopropyl β-d-1-thiogalactopyranoside
- Ni-NTA:
-
Ni2+-nitrilotriacetate
- NusA:
-
N utilization substance A
- RT-PCR:
-
Reverse transcription polymerase chain reaction
- SD:
-
Standard deviations
- SDS-PAGE:
-
Sodium dodecyl sulfate polyacrylamide gel electrophoresis
- vvIBDV:
-
Very virulent IBDV
References
Azad AA, Barrett SA, Fahey KJ (1985) Virology 143:35–44
Azad AA, McKern NM, Macreadie IG, Failla P, Heine HG, Chapman A, Ward CW, Fahey KJ (1991) Vaccine 9:715–722
Bayliss CD, Peters RW, Cook JKA, Reece RL, Howes K, Binns MM, Boursnell MEG (1991) Arch Virol 120:193–205
Becht H, Müller H, Müller HK (1988) J Gen Virol 69:631–640
Chettle N, Stuart JC, Wyeth PJ (1989) Vet Rec 125:271–272
Davis GD, Elisee C, Newham DM, Harrison RG (1999) Biotechnol Bioeng 65:382–388
Douette P, Navet R, Gerkens P, Galleni M, Lévy D, Sluse FE (2005) Biochem Biophys Res Commun 333:686–693
Eterradossi N, Arnauld C, Toquin D, Rivallan G (1998) Arch Virol 143:1627–1636
Ghafari Sh, Seyfiabad Shapouri MR, Moatamedi H, Roayaei M, Goudarzi H (2010) Iran J Vet Res 11:72–77
Giambrone JJ, Eidson CS, Page RK (1976) Avian Dis 20:534–544
Hiraga M, Nunoya T, Otaki Y, Tajima M, Saito T, Nakamura T (1994) J Vet Med Sci 56:1057–1063
Kibenge FSB, Dhillon AS, Russell RG (1988) J Gen Virol 69:1757–1775
Lim AL, Powers-Lee SG (1996) J Biol Chem 271:11400–11409
Luo Y, Huang X, Mckeehan WL (2007) Arch Biochem Biophys 40:17–24
Mundt E, Beyer J, Muller H (1995) J Gen Virol 76:437–443
Nilsson J, Ståhl S, Lundeberg J, Uhlén M, Nygren PA (1997) Protein Expr Purif 11:1–16
Razmyar J, Peighambari SM (2008) Avian Dis 2008(52):665–669
Razmyar J, Peighambari SM (2009) Acta Virol 2009(53):271–276
Rozkov A, Enfors SO (2004) Adv Biochem Eng Biotechnol 89:163–195
Shamsara M, Ghorashi SA, Ahmadian G (2006) Acta Virol 50:229–234
Smith DB, Johnson KS (1988) Gene 67:31–40
Spies U, Müller H, Becht H (1987) Virus Res 8:127–140
Vakharia VN, He J, Ahamed B, Snyder DB (1994) Virus Res 31:265–273
van den Berg TP (2000) Avian Pathol 29:175–194
Villegas P, Hamoud M, Purvis LB, Perozo F (2008) Avian Dis 52:670–674
Wyeth PJ, Gullen GA (1976) Avian Pathol 5:253–260
Yu L, Song AK, Zhang AB, Deng R (2000) Avian Dis 44:170–178
Acknowledgments
The authors thank from National Institute of Genetic Engineering and Biotechnology and Isfahan University of Technology for financial supports.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sedighzadeh, S.S., Shamsara, M. & Shahpiri, A. Fusion Protein Strategy to Increase Expression and Solubility of Hypervariable Region of VP2 Protein of Infectious Bursal Disease Virus in Escherichia coli . Protein J 31, 580–584 (2012). https://doi.org/10.1007/s10930-012-9437-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10930-012-9437-2